San Francisco’s Rock Health startup accelerator unveiled its latest class of startups this week. It’s the fifth group admitted to the digital health program, which provides each of its companies with a $100,000 investment and four months of intensive entrepreneurship training,... Read more »
Scientists have been blown away by things they’ve learned the past couple years about the trillions of bacterial friends and enemies that we human beings live with every day. Now we’re seeing pharmaceutical companies showing more interest in finding new ways... Read more »
In Amazon’s hometown of Seattle, people are pretty used to the sight of bright green Amazon Fresh trucks zipping around the city, loaded down with containers and bags full of groceries delivered to their door.
Now it’s looking like folks in... Read more »
The crops seem to be withering in the land of “FarmVille.”
When social game company Zynga (Nasdaq: ZNGA) announced on Monday plans to cut 520 employees, about 18 percent of its overall staff, its New York, Los Angeles, and... Read more »
Not many companies know how to make peptide molecules that can be packaged in a pill, but Menlo Park, CA-based Protagonist Therapeutics just got a vote of confidence that it can pull off that nifty little trick.
The company is announcing... Read more »
Anybody with a more than passing interest in cancer has been transfixed the last few days by the news coming out of Chicago. The American Society of Clinical Oncology (ASCO) annual meeting has been especially newsy this year, chock full of... Read more »
Remember Plexxikon? The Berkeley, CA-based company had a lot of talent for structural biology-based drug design, an impressive new treatment for melanoma, and a strong management team.
Two years ago, nobody on Wall Street cared one whit. Plexxikon flirted with the... Read more »